# Thrombelastography Based Dosing of Enoxaparin

> **NCT00990236** · NA · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 185 (actual)

## Conditions studied

- Thromboembolic Complications

## Interventions

- **DRUG:** Enoxaparin dose adjusted Lovenox based on TEG
- **DRUG:** Enoxaparin 30 mg BID

## Key facts

- **NCT ID:** NCT00990236
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 185 (ACTUAL)
- **Last updated:** 2020-04-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00990236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00990236, "Thrombelastography Based Dosing of Enoxaparin". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00990236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*